doi: 10.1016/s0960-894x(02)00725-4.
Anticancer activity for 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) analogues and their abilities to interact with lymphoendothelial cell surface markers
Affiliations
- PMID: 12419372
- DOI: 10.1016/s0960-894x(02)00725-4
Item in Clipboard
Anticancer activity for 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) analogues and their abilities to interact with lymphoendothelial cell surface markers
Bioorg Med Chem Lett.
.
Abstract
The structure of the anticancer agent 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) has been modified through SAR and by incorporating barbituric acid, pyridine, quinoline, and alkylcarboxylic acids into A-007's moieties. Analogue anticancer activity and interacting with CD surface markers on a T-cell leukemia cell line were evaluated and the correlation between SAR and biological properties are discussed.
Similar articles
-
Anticancer properties for 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007)/3,7-diaminophenothiazin-5-ium double salts.Bioorg Med Chem Lett. 2001 Aug 20;11(16):2193-5. doi: 10.1016/s0960-894x(01)00408-5. Bioorg Med Chem Lett. 2001. PMID: 11514168
-
Design, synthesis, and anticancer properties of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone and analogues.J Med Chem. 2003 Oct 9;46(21):4552-63. doi: 10.1021/jm0301080. J Med Chem. 2003. PMID: 14521417
-
Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents.Eur J Med Chem. 2014 May 6;78:275-80. doi: 10.1016/j.ejmech.2014.03.058. Epub 2014 Mar 19. Eur J Med Chem. 2014. PMID: 24686014
-
Comparative dermal pharmacology and toxicology of 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007) in rodents and primates.In Vivo. 2001 Nov-Dec;15(6):479-84. In Vivo. 2001. PMID: 11887332
-
Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents.J Med Chem. 2015 Mar 12;58(5):2135-48. doi: 10.1021/jm501123r. Epub 2015 Feb 25. J Med Chem. 2015. PMID: 25668341
Cited by
-
Ball Milling Promoted N-Heterocycles Synthesis.Molecules. 2018 Jun 4;23(6):1348. doi: 10.3390/molecules23061348. Molecules. 2018. PMID: 29867039 Free PMC article. Review.
-
Antibacterial, antiurease, and antioxidant activities of some arylidene barbiturates.Appl Biochem Biotechnol. 2013 Dec;171(8):2030-9. doi: 10.1007/s12010-013-0486-6. Epub 2013 Sep 11. Appl Biochem Biotechnol. 2013. PMID: 24018846 Free PMC article.
-
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K-Ras4b Inhibitors.ChemMedChem. 2022 Nov 18;17(22):e202200392. doi: 10.1002/cmdc.202200392. Epub 2022 Sep 23. ChemMedChem. 2022. PMID: 35979853 Free PMC article.
-
Microwave-assisted synthesis of novel 2H-chromene derivatives bearing phenylthiazolidinones and their biological activity assessment.Molecules. 2014 Nov 26;19(12):19648-64. doi: 10.3390/molecules191219648. Molecules. 2014. PMID: 25432014 Free PMC article.
-
Novel biocompatible core/shell Fe3O4@NFC@Co(ii) as a new catalyst in a multicomponent reaction: an efficient and sustainable methodology and novel reusable material for one-pot synthesis of 4H-pyran and pyranopyrazole in aqueous media.RSC Adv. 2020 Oct 8;10(61):37086-37097. doi: 10.1039/d0ra04698a. eCollection 2020 Oct 7. RSC Adv. 2020. Retraction in: RSC Adv. 2024 Jan 5;14(3):1673. doi: 10.1039/d3ra90127k. PMID: 35521285 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
